Year-End Report — BROWNSTEIN HYATT FARBER SCHRECK, LLP for NEUROMOLECULAR PHARMACEUTICALS (2007)

Firm

BROWNSTEIN HYATT FARBER SCHRECK, LLP

Client

NEUROMOLECULAR PHARMACEUTICALS

Income

$120,000

Expenses

—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Disaster Planning/Emergencies DIS

Issues relating to pandemic influenza and government preparedness

Lobbyist	Covered position, as disclosed
JUDY BLACK	N/A
DAVID PHILLIP COHEN	N/A
TERESA DYER	N/A
C SUZANNE MENCER	N/A
PAMELA SILLARS	N/A

Contacted: HOUSE OF REPRESENTATIVES; Defense, Dept of (DOD); Health & Human Services, Dept of (HHS)

Medical/Disease Research/Clinical Labs MED

Issues relating to pandemic influenza and government preparedness

Lobbyist	Covered position, as disclosed
JUDY BLACK	N/A
DAVID PHILLIP COHEN	N/A
TERESA DYER	N/A
C SUZANNE MENCER	N/A
PAMELA SILLARS	N/A

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Defense, Dept of (DOD)

Pharmacy PHA

Issues relating to pandemic influenza and government preparedness

Lobbyist	Covered position, as disclosed
JUDY BLACK	N/A
DAVID PHILLIP COHEN	N/A
TERESA DYER	N/A
C SUZANNE MENCER	N/A
PAMELA SILLARS	N/A

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Defense, Dept of (DOD)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.